This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Pherin Pharmaceuticals, Inc.. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2014
Title: Louis Monti-Bloch: Innovator in the Treatment of Social Phobia
Introduction
Louis Monti-Bloch is a notable inventor based in Mountain View, CA, who has made significant contributions to the field of pharmacology. With two patents to his name, Monti-Bloch has dedicated his research efforts towards developing innovative treatments for psychological conditions, specifically social phobia.
Latest Patents
Monti-Bloch's latest patent focuses on the acute treatment of social phobia through methods and compositions that involve the administration of an androsta-4,16-dien-3-ol steroid. This invention outlines a pharmaceutical composition containing a therapeutically effective amount of this steroid, designed for individuals in need of treatment for social phobia. The effective dosage range includes amounts between 100 picograms and 100 micrograms, or 1 nanogram to 10 micrograms, among others. The preferred method of administration is intranasal, targeting the nasal passages and the vomeronasal organ of the individual. Notably, the patent encompasses the use of both [3β]-androsta-4,16-dien-3-ol and [3α]-androsta-4,16-dien-3-ol in treatment compositions.
Career Highlights
Monti-Bloch is associated with Pherin Pharmaceuticals, Inc., where his work continues to impact the development of treatments for mental health conditions. His innovative approaches are aligned with the company's mission to address unmet needs in the pharmaceutical landscape, specifically in areas related to psychological well-being.
Collaborations
Throughout his career, Monti-Bloch has likely engaged in collaborations with a variety of professionals and researchers in the pharmaceutical and mental health fields. These collaborations may have played a crucial role in refining his innovative treatments and advancing the science behind social phobia management.
Conclusion
Louis Monti-Bloch is a pioneering inventor whose work in the treatment of social phobia showcases the potential of pharmaceutical innovations in addressing mental health issues. With a focus on effective steroid-based compositions, Monti-Bloch's contributions can significantly enhance the quality of life for individuals grappling with social phobia. His patents reflect the intersection of scientific research and practical application, driving forward new solutions in the realm of mental health treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile